• AJMCAJMC
  • Center for Biosimilars
Center for Biosimilars®
Center for Biosimilars®
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Clinical
Dermatology
Endocrinology
Gastroenterology
Legal
Neurology
Oncology
Ophthalmology
Rare Disease
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Polls
Subscribe
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2021 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.

Global Perspective on the Effect of Biosimilars

EP 1: Comparison of Biologics to Biosimilars Versus Generics

October 10th 2018

EP 2: The BPCIA and the Naming of Biosimilars

October 10th 2018

EP 3: The Approval Process for Biosimilars

October 10th 2018

EP 4: Considerations for Approving Generics Versus Biosimilars

October 10th 2018

EP 5: Interchangeability and Postmarketing Pharmacovigilance of Biosimilars

October 10th 2018

EP 6: Experience Prescribing Biosimilars Versus Biologics

October 10th 2018

EP 7: The Impact of Access to Biosimilars

October 10th 2018

EP 8: US and EU Biosimilar Pricing and Stakeholder Education

October 10th 2018

EP 9: Formulary Approval and Challenges for Payers

October 10th 2018

EP 10: Prescribing Biosimilars and Educating Patients and Physicians

October 10th 2018

EP 11: The Influence of Biosimilars in Cancer Care

October 10th 2018

EP 12: Biosimilars in the Pipeline and Disease Management

October 10th 2018

EP 13: Outlook on the Future of Biosimilars

October 10th 2018